{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:31:13Z","timestamp":1776396673799,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Graduate Innovation Fund\u2002of Jilin University","award":["451230411126"],"award-info":[{"award-number":["451230411126"]}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20220508085RC"],"award-info":[{"award-number":["20220508085RC"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87201-6","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:06:30Z","timestamp":1739289990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The antidiabetic effect of safflower yellow by regulating the GOAT\/ghrelin\/GHS-R1a\/cAMP\/TRPM2 pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Yunxiao","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"87201_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2017.00006","volume":"8","author":"A Chaudhury","year":"2017","unstructured":"Chaudhury, A. et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front. Endocrinol. 8, 6. https:\/\/doi.org\/10.3389\/fendo.2017.00006 (2017).","journal-title":"Front. Endocrinol."},{"key":"87201_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-030-64872-5_13","volume":"1308","author":"A Mahdavi","year":"2021","unstructured":"Mahdavi, A., Bagherniya, M., Mirenayat, M. S., Atkin, S. L. & Sahebkar, A. Medicinal plants and phytochemicals regulating insulin resistance and glucose homeostasis in type 2 diabetic patients: a clinical review. Adv. Exp. Med. Biol. 1308, 161\u2013183. https:\/\/doi.org\/10.1007\/978-3-030-64872-5_13 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"87201_CR3","doi-asserted-by":"publisher","first-page":"8259280","DOI":"10.1155\/2018\/8259280","volume":"2018","author":"H Ao","year":"2018","unstructured":"Ao, H., Feng, W. & Peng, C. Hydroxysafflor yellow A: a promising therapeutic agent for a broad spectrum of diseases. Evid.-Based Complement. Altern. Med. eCAM 2018, 8259280. https:\/\/doi.org\/10.1155\/2018\/8259280 (2018).","journal-title":"Evid.-Based Complement. Altern. Med. eCAM"},{"key":"87201_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fphar.2016.00127","volume":"7","author":"H Zhu","year":"2016","unstructured":"Zhu, H. et al. The mechanism by which safflower yellow decreases body fat mass and improves insulin sensitivity in HFD-induced obese mice. Front. Pharmacol. 7, 127. https:\/\/doi.org\/10.3389\/fphar.2016.00127 (2016).","journal-title":"Front. Pharmacol."},{"key":"87201_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.phrs.2018.05.012","volume":"134","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol. Res. 134, 40\u201350. https:\/\/doi.org\/10.1016\/j.phrs.2018.05.012 (2018).","journal-title":"Pharmacol. Res."},{"key":"87201_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2020.00482","volume":"11","author":"K Yan","year":"2020","unstructured":"Yan, K. et al. Safflower yellow and its main component HSYA alleviate diet-induced obesity in mice: possible involvement of the increased antioxidant enzymes in liver and adipose tissue. Front. Pharmacol. 11, 482. https:\/\/doi.org\/10.3389\/fphar.2020.00482 (2020).","journal-title":"Front. Pharmacol."},{"key":"87201_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656\u2013660. https:\/\/doi.org\/10.1038\/45230 (1999).","journal-title":"Nature"},{"key":"87201_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","volume":"4","author":"TD M\u00fcller","year":"2015","unstructured":"M\u00fcller, T. D. et al. Ghrelin. Mol. Metab. 4, 437\u2013460. https:\/\/doi.org\/10.1016\/j.molmet.2015.03.005 (2015).","journal-title":"Mol. Metab."},{"key":"87201_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","volume":"132","author":"J Yang","year":"2008","unstructured":"Yang, J., Brown, M. S., Liang, G., Grishin, N. V. & Goldstein, J. L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387\u2013396. https:\/\/doi.org\/10.1016\/j.cell.2008.01.017 (2008).","journal-title":"Cell"},{"key":"87201_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/obr.12474","volume":"18","author":"R Churm","year":"2017","unstructured":"Churm, R., Davies, J. S., Stephens, J. W. & Prior, S. L. Ghrelin function in human obesity and type 2 diabetes: a concise review. Obes. Rev. 18, 140\u2013148. https:\/\/doi.org\/10.1111\/obr.12474 (2017).","journal-title":"Obes. Rev."},{"key":"87201_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040798","author":"G Colld\u00e9n","year":"2017","unstructured":"Colld\u00e9n, G., Tsch\u00f6p, M. H. & M\u00fcller, T. D. Therapeutic potential of targeting the ghrelin pathway. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18040798 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"87201_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110835","volume":"511","author":"A Lindqvist","year":"2020","unstructured":"Lindqvist, A. et al. Ghrelin suppresses insulin secretion in human islets and type 2 diabetes patients have diminished islet ghrelin cell number and lower plasma ghrelin levels. Mol. Cell. Endocrinol. 511, 110835. https:\/\/doi.org\/10.1016\/j.mce.2020.110835 (2020).","journal-title":"Mol. Cell. Endocrinol."},{"key":"87201_CR13","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/eje-14-0183","volume":"171","author":"KM Heppner","year":"2014","unstructured":"Heppner, K. M. & Tong, J. Mechanisms in endocrinology: regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions. Eur. J. Endocrinol. 171, R21-32. https:\/\/doi.org\/10.1530\/eje-14-0183 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"87201_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2006.04.004","volume":"3","author":"Y Sun","year":"2006","unstructured":"Sun, Y., Asnicar, M., Saha, P. K., Chan, L. & Smith, R. G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob\/ob mice. Cell Metab. 3, 379\u2013386. https:\/\/doi.org\/10.1016\/j.cmet.2006.04.004 (2006).","journal-title":"Cell Metab."},{"key":"87201_CR15","doi-asserted-by":"publisher","first-page":"7467","DOI":"10.1073\/pnas.1002271107","volume":"107","author":"TJ Zhao","year":"2010","unstructured":"Zhao, T. J. et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc. Natl. Acad. Sci. U.S.A. 107, 7467\u20137472. https:\/\/doi.org\/10.1073\/pnas.1002271107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"87201_CR16","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.3892\/etm.2017.5136","volume":"14","author":"B Pang","year":"2017","unstructured":"Pang, B. et al. Glucagon-like peptide-1 potentiates glucose-stimulated insulin secretion via the transient receptor potential melastatin 2 channel. Exp. Ther. Med. 14, 5219\u20135227. https:\/\/doi.org\/10.3892\/etm.2017.5136 (2017).","journal-title":"Exp. Ther. Med."},{"key":"87201_CR17","doi-asserted-by":"publisher","first-page":"14041","DOI":"10.1038\/srep14041","volume":"5","author":"T Kurashina","year":"2015","unstructured":"Kurashina, T. et al. The \u03b2-cell GHSR and downstream cAMP\/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Sci. Rep. 5, 14041. https:\/\/doi.org\/10.1038\/srep14041 (2015).","journal-title":"Sci. Rep."},{"key":"87201_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"87201_CR19","unstructured":"H.M.A.D.A. et al. Amber 2021, (University of California, 2021)."},{"key":"87201_CR20","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122. https:\/\/doi.org\/10.1038\/nprot.2014.138 (2014).","journal-title":"Nat. Protoc."},{"key":"87201_CR21","first-page":"319","volume":"49","author":"MH Ullman-Culler\u00e9","year":"1999","unstructured":"Ullman-Culler\u00e9, M. H. & Foltz, C. J. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab. Anim. Sci. 49, 319\u2013323 (1999).","journal-title":"Lab. Anim. Sci."},{"key":"87201_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116227","volume":"154","author":"OD Awosanya","year":"2022","unstructured":"Awosanya, O. D. et al. Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone 154, 116227. https:\/\/doi.org\/10.1016\/j.bone.2021.116227 (2022).","journal-title":"Bone"},{"key":"87201_CR23","first-page":"313","volume":"63","author":"EA Nunamaker","year":"2013","unstructured":"Nunamaker, E. A., Anderson, R. J., Artwohl, J. E., Lyubimov, A. V. & Fortman, J. D. Predictive observation-based endpoint criteria for mice receiving total body irradiation. Comp. Med. 63, 313\u2013322 (2013).","journal-title":"Comp. Med."},{"key":"87201_CR24","first-page":"277","volume":"52","author":"FC Hankenson","year":"2013","unstructured":"Hankenson, F. C. et al. Weight loss and reduced body temperature determine humane endpoints in a mouse model of ocular herpesvirus infection. J. Am. Assoc. Lab. Anim. Sci. 52, 277\u2013285 (2013).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"87201_CR25","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1039\/d0fo00395f","volume":"11","author":"X Xia","year":"2020","unstructured":"Xia, X. et al. Jiaogulan tea (Gpostemma pentaphyllum) potentiates the antidiabetic effect of white tea via the AMPK and PI3K pathways in C57BL\/6 mice. Food Funct. 11, 4339\u20134355. https:\/\/doi.org\/10.1039\/d0fo00395f (2020).","journal-title":"Food Funct."},{"key":"87201_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1758-5996-6-42","volume":"6","author":"C Mega","year":"2014","unstructured":"Mega, C. et al. Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat\u2014focus on amelioration of metabolic profile and tissue cytoprotective properties. Diabetol. Metab. Syndr. 6, 42. https:\/\/doi.org\/10.1186\/1758-5996-6-42 (2014).","journal-title":"Diabetol. Metab. Syndr."},{"key":"87201_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/592760","volume":"2010","author":"L Ferreira","year":"2010","unstructured":"Ferreira, L. et al. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediat. Inflamm. 2010, 592760. https:\/\/doi.org\/10.1155\/2010\/592760 (2010).","journal-title":"Mediat. Inflamm."},{"key":"87201_CR28","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick, B. et al. Target identification using drug affinity responsive target stability (DARTS). Proc. Natl. Acad. Sci. U. S. A. 106, 21984\u201321989. https:\/\/doi.org\/10.1073\/pnas.0910040106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"87201_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/adt.2011.0390","volume":"10","author":"G Senisterra","year":"2012","unstructured":"Senisterra, G., Chau, I. & Vedadi, M. Thermal denaturation assays in chemical biology. Assay Drug Dev. Technol. 10, 128\u2013136. https:\/\/doi.org\/10.1089\/adt.2011.0390 (2012).","journal-title":"Assay Drug Dev. Technol."},{"key":"87201_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.biopha.2017.12.099","volume":"98","author":"XM Shi","year":"2018","unstructured":"Shi, X. M. et al. Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP\/PS1 transgenic mice. Biomed. Pharmacother. 98, 553\u2013565. https:\/\/doi.org\/10.1016\/j.biopha.2017.12.099 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"87201_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2147\/dmso.S246381","volume":"13","author":"M Lee","year":"2020","unstructured":"Lee, M., Li, H., Zhao, H., Suo, M. & Liu, D. Effects of hydroxysafflor Yellow A on the PI3K\/AKT pathway and apoptosis of pancreatic \u03b2-cells in type 2 diabetes mellitus rats. Diabetes Metab. Syndr. Obes. Targets Ther. 13, 1097\u20131107. https:\/\/doi.org\/10.2147\/dmso.S246381 (2020).","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"87201_CR32","doi-asserted-by":"publisher","first-page":"7805393","DOI":"10.1155\/2020\/7805393","volume":"2020","author":"M Lee","year":"2020","unstructured":"Lee, M. et al. Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat. Oxid. Med. Cell. Longev. 2020, 7805393. https:\/\/doi.org\/10.1155\/2020\/7805393 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"87201_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/bi5010359","volume":"54","author":"JE Darling","year":"2015","unstructured":"Darling, J. E. et al. Structure-activity analysis of human ghrelin O-acyltransferase reveals chemical determinants of ghrelin selectivity and acyl group recognition. Biochemistry 54, 1100\u20131110. https:\/\/doi.org\/10.1021\/bi5010359 (2015).","journal-title":"Biochemistry"},{"key":"87201_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/13543776.2020.1776263","volume":"30","author":"JE Moose","year":"2020","unstructured":"Moose, J. E., Leets, K. A., Mate, N. A., Chisholm, J. D. & Hougland, J. L. An overview of ghrelin O-acyltransferase inhibitors: a literature and patent review for 2010\u20132019. Expert Opin. Ther. Patents 30, 581\u2013593. https:\/\/doi.org\/10.1080\/13543776.2020.1776263 (2020).","journal-title":"Expert Opin. Ther. Patents"},{"key":"87201_CR35","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.19540\/j.cnki.cjcmm.20170907.008","volume":"42","author":"KW Zeng","year":"2017","unstructured":"Zeng, K. W. & Tu, P. F. Current status and challenging of direct target study of traditional Chinese medicine complex system based on solid coupling beads. China J. Chin. Materia Medica 42, 3645\u20133649. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20170907.008 (2017).","journal-title":"China J. Chin. Materia Medica"},{"key":"87201_CR36","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1021\/acs.jafc.1c07819","volume":"70","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Identification of adenylate kinase 5 as a protein target of ginsenosides in brain tissues using mass spectrometry-based drug affinity responsive target stability (DARTS) and cellular thermal shift assay (CETSA) techniques. J. Agric. Food Chem. 70, 2741\u20132751. https:\/\/doi.org\/10.1021\/acs.jafc.1c07819 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"87201_CR37","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","volume":"52","author":"SM P\u00f6ykk\u00f6","year":"2003","unstructured":"P\u00f6ykk\u00f6, S. M. et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52, 2546\u20132553. https:\/\/doi.org\/10.2337\/diabetes.52.10.2546 (2003).","journal-title":"Diabetes"},{"key":"87201_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/joe-11-0147","volume":"211","author":"L Huang","year":"2011","unstructured":"Huang, L. et al. Influence of fasting, insulin and glucose on ghrelin in the dorsal vagal complex in rats. J. Endocrinol. 211, 257\u2013262. https:\/\/doi.org\/10.1530\/joe-11-0147 (2011).","journal-title":"J. Endocrinol."},{"key":"87201_CR39","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.2337\/diabetes.53.12.3142","volume":"53","author":"K Dezaki","year":"2004","unstructured":"Dezaki, K. et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 53, 3142\u20133151. https:\/\/doi.org\/10.2337\/diabetes.53.12.3142 (2004).","journal-title":"Diabetes"},{"key":"87201_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/002215540405200301","volume":"52","author":"N Wierup","year":"2004","unstructured":"Wierup, N., Yang, S., McEvilly, R. J., Mulder, H. & Sundler, F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832\/13) cells. J. Histochem. Cytochem. 52, 301\u2013310. https:\/\/doi.org\/10.1177\/002215540405200301 (2004).","journal-title":"J. Histochem. Cytochem."},{"key":"87201_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1365-2826.2002.00811.x","volume":"14","author":"E Adeghate","year":"2002","unstructured":"Adeghate, E. & Ponery, A. S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J. Neuroendocrinol. 14, 555\u2013560. https:\/\/doi.org\/10.1046\/j.1365-2826.2002.00811.x (2002).","journal-title":"J. Neuroendocrinol."},{"key":"87201_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.51.1.124","volume":"51","author":"Y Date","year":"2002","unstructured":"Date, Y. et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 51, 124\u2013129. https:\/\/doi.org\/10.2337\/diabetes.51.1.124 (2002).","journal-title":"Diabetes"},{"key":"87201_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12017-020-08591-6","volume":"22","author":"J Pang","year":"2020","unstructured":"Pang, J. et al. Safflower yellow improves synaptic plasticity in APP\/PS1 mice by regulating microglia activation phenotypes and BDNF\/TrkB\/ERK signaling pathway. Neuromol. Med. 22, 341\u2013358. https:\/\/doi.org\/10.1007\/s12017-020-08591-6 (2020).","journal-title":"Neuromol. Med."},{"key":"87201_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pbiomolbio.2011.07.005","volume":"107","author":"CA Leech","year":"2011","unstructured":"Leech, C. A. et al. Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic \u03b2 cells. Progr. Biophys. Mol. Biol. 107, 236\u2013247. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2011.07.005 (2011).","journal-title":"Progr. Biophys. Mol. Biol."},{"key":"87201_CR45","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.2337\/db13-1868","volume":"63","author":"M Yosida","year":"2014","unstructured":"Yosida, M. et al. Involvement of cAMP\/EPAC\/TRPM2 activation in glucose- and incretin-induced insulin secretion. Diabetes 63, 3394\u20133403. https:\/\/doi.org\/10.2337\/db13-1868 (2014).","journal-title":"Diabetes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87201-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:32:15Z","timestamp":1739460735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87201"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87201-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5037"}}